{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T09:49:22Z","timestamp":1750931362733},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T00:00:00Z","timestamp":1547856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13256-018-1943-1","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T04:44:04Z","timestamp":1547441044000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Delayed hemolysis, elevated liver enzymes, low platelet count syndrome in succession of switches of preventive anticoagulant treatment in a 41-year-old patient with a history of recurrent assisted implantation failures: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Katrin","family":"Mikolaiczik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Praetner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"R\u00fcth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karlheinz","family":"Mark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,19]]},"reference":[{"key":"1943_CR1","unstructured":"Mathews TJ, Hamilton BE. Mean Age of Mothers is on the Rise: United States, 2000-2014. NCHS Data Brief. 2016;232:1\u20138."},{"key":"1943_CR2","unstructured":"Eurostat - Tables, Graphs and Maps Interface (TGM) table. Mean age of women at childbirth and at birth of first child. \n                    http:\/\/ec.europa.eu\/eurostat\/tgm\/table.do?tab=table&init=1&language=en&pcode=tps00017&plugin=1\n                    \n                  . Accessed 1 Feb 2017."},{"key":"1943_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/01.AOG.0000100153.24061.45","volume":"103","author":"DB Dunson","year":"2004","unstructured":"Dunson DB, Baird DD, Colombo B. Increased Infertility With Age in Men and Women. Obstet Gynecol. 2004;103:51\u20136. \n                    https:\/\/doi.org\/10.1097\/01.AOG.0000100153.24061.45\n                    \n                  .","journal-title":"Obstet Gynecol"},{"key":"1943_CR4","doi-asserted-by":"publisher","unstructured":"Lamminpaa R, Vehvilainen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008. BMC Pregnancy Childbirth. 2012;12(47) \n                    https:\/\/doi.org\/10.1186\/1471-2393-12-47.","DOI":"10.1186\/1471-2393-12-47."},{"key":"1943_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","volume":"330","author":"K Duckitt","year":"2005","unstructured":"Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:565. \n                    https:\/\/doi.org\/10.1136\/bmj.38380.674340.E0\n                    \n                  .","journal-title":"BMJ"},{"key":"1943_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/humrep\/dev319.","volume":"31","author":"MS Kupka","year":"2016","unstructured":"Kupka MS, D\u2019Hooghe T, Ferraretti AP, de Mouzon J, Erb K, Castilla JA, et al. Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHRE. Hum Reprod. 2016;31:233\u201348. \n                    https:\/\/doi.org\/10.1093\/humrep\/dev319.","journal-title":"Hum Reprod"},{"key":"1943_CR7","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1160\/TH14-10-0848","volume":"113","author":"SA Mastrolia","year":"2015","unstructured":"Mastrolia SA, Mazor M, Holcberg G, Leron E, Beharier O, Loverro G, Erez O. The physiologic anticoagulant and anti-inflammatory role of heparins and their utility in the prevention of pregnancy complications. Thromb Haemost. 2015;113:1236\u201346. \n                    https:\/\/doi.org\/10.1160\/TH14-10-0848\n                    \n                  .","journal-title":"Thromb Haemost"},{"key":"1943_CR8","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1111\/j.1538-7836.2011.04535.x","volume":"9","author":"F Dentali","year":"2011","unstructured":"Dentali F, Grandone E, Rezoagli E, Ageno W. Efficacy of low molecular weight heparin in patients undergoing in vitro fertilization or intracytoplasmic sperm injection. J Thromb Haemost. 2011;9:2503\u20136. \n                    https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04535.x\n                    \n                  .","journal-title":"J Thromb Haemost"},{"key":"1943_CR9","doi-asserted-by":"publisher","unstructured":"Akhtar MA, Sur S, Raine-Fenning N, Jayaprakasan K, Thornton JG, Quenby S. Heparin for assisted reproduction. Cochrane Database Syst Rev. 2013:CD009452. \n                    https:\/\/doi.org\/10.1002\/14651858.CD009452.pub2.","DOI":"10.1002\/14651858.CD009452.pub2."},{"key":"1943_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/humupd\/dmt032","volume":"19","author":"N Potdar","year":"2013","unstructured":"Potdar N, Gelbaya TA, Konje JC, Nardo LG. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Hum Reprod Update. 2013;19:674\u201384. \n                    https:\/\/doi.org\/10.1093\/humupd\/dmt032\n                    \n                  .","journal-title":"Hum Reprod Update"},{"key":"1943_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/humrep\/den476.","volume":"24","author":"K Dirckx","year":"2009","unstructured":"Dirckx K, Cabri P, Merien A, Galajdova L, Gerris J, Dhont M, de Sutter P. Does low-dose aspirin improve pregnancy rate in IVF\/ICSI? A randomized double-blind placebo controlled trial. Hum Reprod. 2009;24:856\u201360. \n                    https:\/\/doi.org\/10.1093\/humrep\/den476.","journal-title":"Hum Reprod"},{"key":"1943_CR12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1023\/A:1026491426423.","volume":"17","author":"U Bulent","year":"2000","unstructured":"Bulent U, Ramazan M, Cengiz A, Basak B, Aycan I, Alp N. Low-Dose Aspirin Does Not Increase Implantation Rates in Patients Undergoing Intracytoplasmic Sperm Injection: A Prospective Randomized Study. J Assist Reprod Genet. 2000;17:586\u201390. \n                    https:\/\/doi.org\/10.1023\/A:1026491426423.","journal-title":"J Assist Reprod Genet"},{"key":"1943_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM199803123381101.","volume":"338","author":"S Caritis","year":"1998","unstructured":"Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338:701\u20135. \n                    https:\/\/doi.org\/10.1056\/NEJM199803123381101.","journal-title":"N Engl J Med"},{"key":"1943_CR14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","volume":"160","author":"JT Henderson","year":"2014","unstructured":"Henderson JT, Whitlock EP, O\u2019Conner E, Senger CA, Thompson JH, Rowland MG. Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:695\u2013703.","journal-title":"Ann Intern Med"},{"key":"1943_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","volume":"116","author":"E Bujold","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402\u201314. \n                    https:\/\/doi.org\/10.1097\/AOG.0b013e3181e9322a\n                    \n                  .","journal-title":"Obstet Gynecol"},{"key":"1943_CR16","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1056\/NEJM199310213291701.","volume":"329","author":"BM Sibai","year":"1993","unstructured":"Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1993;329:1213\u20138. \n                    https:\/\/doi.org\/10.1056\/NEJM199310213291701.","journal-title":"N Engl J Med"},{"key":"1943_CR17","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/uog.15789","volume":"47","author":"S Roberge","year":"2016","unstructured":"Roberge S, Demers S, Nicolaides KH, Bureau M, Cote S, Bujold E. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis. Ultrasound Obstet Gynecol. 2016;47:548\u201353. \n                    https:\/\/doi.org\/10.1002\/uog.15789\n                    \n                  .","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1943_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1161\/01.HYP.0000149950.05182.a3","volume":"45","author":"G Mello","year":"2005","unstructured":"Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension. 2005;45:86\u201391. \n                    https:\/\/doi.org\/10.1161\/01.HYP.0000149950.05182.a3\n                    \n                  .","journal-title":"Hypertension"},{"key":"1943_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/10641950600745517.","volume":"25","author":"F Sergio","year":"2006","unstructured":"Sergio F, Maria Clara DA, Gabriella F, Giorgia S, Sara DC, Giancarlo P, Alessandro C. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy. 2006;25:115\u201327. \n                    https:\/\/doi.org\/10.1080\/10641950600745517.","journal-title":"Hypertens Pregnancy"},{"key":"1943_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11906-016-0664-3","volume":"18","author":"V Katsi","year":"2016","unstructured":"Katsi V, Kanellopoulou T, Makris T, Nihoyannopoulos P, Nomikou E, Tousoulis D. Aspirin vs Heparin for the Prevention of Preeclampsia. Curr Hypertens Rep. 2016;18:57. \n                    https:\/\/doi.org\/10.1007\/s11906-016-0664-3\n                    \n                  .","journal-title":"Curr Hypertens Rep"},{"key":"1943_CR21","doi-asserted-by":"publisher","unstructured":"Groom KM, McCowan LM, Mackay LK, Lee AC, Said JM, Kane SC, et al. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial. Am J Obstet Gynecol. 2017; \n                    https:\/\/doi.org\/10.1016\/j.ajog.2017.01.014\n                    \n                  .","DOI":"10.1016\/j.ajog.2017.01.014"},{"key":"1943_CR22","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","volume":"388","author":"MA Rodger","year":"2016","unstructured":"Rodger MA, Gris J-C, de Vries JIP, Martinelli I, Rey \u00c9, Schleussner E, et al. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: A meta-analysis of individual patient data from randomised controlled trials. Lancet. 2016;388:2629\u201341. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)31139-4\n                    \n                  .","journal-title":"Lancet"},{"key":"1943_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1515\/JPM.2000.033","volume":"28","author":"W Rath","year":"2000","unstructured":"Rath W, Faridi A, Dudenhausen JW. HELLP syndrome. J Perinat Med. 2000;28:249\u201360. \n                    https:\/\/doi.org\/10.1515\/JPM.2000.033\n                    \n                  .","journal-title":"J Perinat Med"},{"key":"1943_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstr\u00f6m M, et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016;374:13\u201322. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1414838\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1943_CR25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.preghy.2014.04.019","volume":"4","author":"B Abimanyu","year":"2014","unstructured":"Abimanyu B. The role of angiogenic factors in pre-eclampsia. Pregnancy Hypertens. 2014;4:246. \n                    https:\/\/doi.org\/10.1016\/j.preghy.2014.04.019\n                    \n                  .","journal-title":"Pregnancy Hypertens."},{"key":"1943_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jogoh.2017.10.007","volume":"47","author":"C Tardif","year":"2018","unstructured":"Tardif C, Dumontet E, Caillon H, Misbert E, Dochez V, Masson D, Winer N. Angiogenic factors sFlt-1 and PlGF in preeclampsia: Prediction of risk and prognosis in a high-risk obstetric population. J Gynecol Obstet Hum Reprod. 2018;47:17\u201321. \n                    https:\/\/doi.org\/10.1016\/j.jogoh.2017.10.007\n                    \n                  .","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"1943_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","volume":"71","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Cerdeira AS, Redman C, Vatish M. Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study. Hypertension. 2018;71:306\u201316. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10182\n                    \n                  .","journal-title":"Hypertension"},{"key":"1943_CR28","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","volume":"335","author":"L Bellamy","year":"2007","unstructured":"Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974. \n                    https:\/\/doi.org\/10.1136\/bmj.39335.385301.BE\n                    \n                  .","journal-title":"BMJ"},{"key":"1943_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10654-013-9762-6.","volume":"28","author":"MC Brown","year":"2013","unstructured":"Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28:1\u201319. \n                    https:\/\/doi.org\/10.1007\/s10654-013-9762-6.","journal-title":"Eur J Epidemiol"},{"key":"1943_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rbmo.2011.10.003","volume":"24","author":"S Campo","year":"2012","unstructured":"Campo S, Campo V, Benagiano G. Adenomyosis and infertility. Reprod BioMed Online. 2012;24:35\u201346. \n                    https:\/\/doi.org\/10.1016\/j.rbmo.2011.10.003\n                    \n                  .","journal-title":"Reprod BioMed Online"},{"key":"1943_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.rbmo.2012.05.003","volume":"25","author":"R Salim","year":"2012","unstructured":"Salim R, Riris S, Saab W, Abramov B, Khadum I, Serhal P. Adenomyosis reduces pregnancy rates in infertile women undergoing IVF. Reprod BioMed Online. 2012;25:273\u20137. \n                    https:\/\/doi.org\/10.1016\/j.rbmo.2012.05.003\n                    \n                  .","journal-title":"Reprod BioMed Online"},{"key":"1943_CR32","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.01.051","volume":"91","author":"EA Pritts","year":"2009","unstructured":"Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009;91:1215\u201323. \n                    https:\/\/doi.org\/10.1016\/j.fertnstert.2008.01.051\n                    \n                  .","journal-title":"Fertil Steril"},{"key":"1943_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bpobgyn.2011.01.007","volume":"25","author":"L Trogstad","year":"2011","unstructured":"Trogstad L, Magnus P, Stoltenberg C. Pre-eclampsia: Risk factors and causal models. Best Pract Res Clin Obstet Gynaecol. 2011;25:329\u201342. \n                    https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.01.007\n                    \n                  .","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1943_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/jhh.2012.13","volume":"27","author":"C Thomopoulos","year":"2013","unstructured":"Thomopoulos C, Tsioufis C, Michalopoulou H, Makris T, Papademetriou V, Stefanadis C. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens. 2013;27:148\u201357. \n                    https:\/\/doi.org\/10.1038\/jhh.2012.13\n                    \n                  .","journal-title":"J Hum Hypertens"},{"key":"1943_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preghy.2012.01.001","volume":"2","author":"JM Roberts","year":"2012","unstructured":"Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens. 2012;2:72\u201383. \n                    https:\/\/doi.org\/10.1016\/j.preghy.2012.01.001\n                    \n                  .","journal-title":"Pregnancy Hypertens"},{"key":"1943_CR36","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1471-0528.1972.tb12922.x","volume":"79","author":"I Brosens","year":"1972","unstructured":"Brosens I, Renaer M. On the pathogenesis of placental infarcts in pre-eclampsia. BJOG: Int J O&G. 1972;79:794\u20139. \n                    https:\/\/doi.org\/10.1111\/j.1471-0528.1972.tb12922.x\n                    \n                  .","journal-title":"BJOG: Int J O&G"},{"key":"1943_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3109\/10641950903572282","volume":"29","author":"JL Merwe van der","year":"2010","unstructured":"van der Merwe JL, Hall DR, Wright C, Schubert P, Grove D. Are early and late preeclampsia distinct subclasses of the disease--what does the placenta reveal? Hypertens Pregnancy. 2010;29:457\u201367. \n                    https:\/\/doi.org\/10.3109\/10641950903572282\n                    \n                  .","journal-title":"Hypertens Pregnancy."},{"key":"1943_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0412.2010.01012.x","volume":"90","author":"M-T Vinnars","year":"2011","unstructured":"Vinnars M-T, Nasiell J, Ghazi S, Westgren M, Papadogiannakis N. The severity of clinical manifestations in preeclampsia correlates with the amount of placental infarction. Acta Obstet Gynecol Scand. 2011;90:19\u201325. \n                    https:\/\/doi.org\/10.1111\/j.1600-0412.2010.01012.x\n                    \n                  .","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1943_CR39","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1161\/HYPERTENSIONAHA.107.104844","volume":"51","author":"M-T Vinnars","year":"2008","unstructured":"Vinnars M-T, Wijnaendts LCD, Westgren M, Bolte AC, Papadogiannakis N, Nasiell J. Severe preeclampsia with and without HELLP differ with regard to placental pathology. Hypertension. 2008;51:1295\u20139. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.104844\n                    \n                  .","journal-title":"Hypertension"},{"key":"1943_CR40","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.7863\/jum.2010.29.7.1103","volume":"29","author":"J Espinoza","year":"2010","unstructured":"Espinoza J, Kusanovic JP, Bahado-Singh R, Gervasi MT, Romero R, Lee W, et al. Should bilateral uterine artery notching be used in the risk assessment for preeclampsia, small-for-gestational-age, and gestational hypertension? J Ultrasound Med. 2010;29:1103\u201315.","journal-title":"J Ultrasound Med"},{"key":"1943_CR41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/uog.13224","volume":"43","author":"PI Gomez-Arriaga","year":"2014","unstructured":"Gomez-Arriaga PI, Herraiz I, Lopez-Jimenez EA, Escribano D, Denk B, Galindo A. Uterine artery Doppler and sFlt-1\/PlGF ratio: prognostic value in early-onset pre-eclampsia. Ultrasound Obstet Gynecol. 2014;43:525\u201332. \n                    https:\/\/doi.org\/10.1002\/uog.13224\n                    \n                  .","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1943_CR42","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1515\/cclm-2013-0955","volume":"52","author":"J-C Forest","year":"2014","unstructured":"Forest J-C, Theriault S, Masse J, Bujold E, Giguere Y. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women. Clin Chem Lab Med. 2014;52:1169\u201378. \n                    https:\/\/doi.org\/10.1515\/cclm-2013-0955\n                    \n                  .","journal-title":"Clin Chem Lab Med"},{"key":"1943_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/uog.6782","volume":"34","author":"I Herraiz","year":"2009","unstructured":"Herraiz I, L\u00f3pez-Jim\u00e9nez EA, Puente JM, Cama\u00f1o I, Arbu\u00e9s J, Galindo A. OP14.07: Uterine artery Doppler and sFlt1\/PlGF ratio as useful tools to predict severe complications after the diagnosis of preeclampsia is confirmed. Ultrasound Obstet Gynecol. 2009;34:105\u20136. \n                    https:\/\/doi.org\/10.1002\/uog.6782\n                    \n                  .","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1943_CR44","doi-asserted-by":"publisher","first-page":"172808","DOI":"10.5402\/2012\/172808.","volume":"2012","author":"B Mikat","year":"2012","unstructured":"Mikat B, Gellhaus A, Wagner N, Birdir C, Kimmig R, Koninger A. Early detection of maternal risk for preeclampsia. ISRN Obstet Gynecol. 2012;2012:172808. \n                    https:\/\/doi.org\/10.5402\/2012\/172808.","journal-title":"ISRN Obstet Gynecol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1943-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1943-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1943-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T19:06:35Z","timestamp":1579374395000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1943-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,19]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1943-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,19]]},"assertion":[{"value":"18 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"16"}}